-Michael E Phelps Researcher Activity Profile

Research Author Detailed Information 

Michael E Phelps Publication Rate By Year

Michael E Phelps has published 1 paper(s) in 1987, 11 paper(s) in 2007, 3 paper(s) in 2008, for a total of 15 research publications in total.

Michael E Me Phelps Author Information

LAST NAME: phelps

FIRST NAME: Michael E

INITIALS: me

AFFILIATION:

Papers

Michael E Phelps's Publication Record

1. Predicting seizure-free status for temporal lobe epilepsy patients undergoing surgery: prognostic value of quantifying maximal metabolic asymmetry extending over a specified proportion of the temporal lobe. Year Published: 2007
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095-6942, USA.
2. In vivo quantitation of glucose metabolism in mice using small-animal PET and a microfluidic device. Year Published: 2007
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095-6948, USA. cwu@mednet.ucla.edu
3. Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis. Year Published: 2007
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
4. A phenotypic small-molecule screen identifies an orphan ligand-receptor pair that regulates neural stem cell differentiation. Year Published: 2007
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
5. Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study. Year Published: 2007
Ahmanson Biological Imaging Division and the Department of Molecular and Medical Pharmacology, Biostatistics, Radiology,University of California, Los Angeles, Los Angeles, CA 90005-6942, USA. weichen@mednet.ucla.edu
6. Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs. Year Published: 2007
WA Weber is Professor and Director of Nuclear Medicine at the University of Freiberg, Germany.
7. Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs. Year Published: 2007
Nuclear Medicine, University of Freiberg, Germany.
8. Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs. Year Published: 2007
Nuclear Medicine, University of Freiberg, Germany.
9. An evaluation of Bayesian regression for estimating cerebral oxygen utilization with oxygen-15 and dynamic PET. Year Published: 2008
California Univ., Los Angeles, CA.
10. Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs. Year Published: 2007
Nuclear Medicine, University of Freiberg, Germany.
11. Biodistribution and predictive value of 18F-fluorocyclophosphamide in mice bearing human breast cancer xenografts. Year Published: 2007
Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California 90095-6942, USA.
12. Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas. Year Published: 2008
Authors' Affiliations: Abteilung Nuklearmedizin (University of Freiburg), Freiburg, Germany.
13. A Realistic Computer-Simulated Brain Phantom for Evaluation of PET Charactenstics. Year Published: 2008
14. Biodistribution and predictive value of 18F-fluorocyclophosphamide in mice bearing human breast cancer xenografts. Year Published: 2007
Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California 90095-6942, USA.
15. No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography. Year Published: 1987